1.Research progress on indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Ting WANG ; Hui WEN ; Hua-qing CUI ; Da-li YIN
Acta Pharmaceutica Sinica 2021;56(3):723-733
Indoleamine 2,3-dioxygenase 1 (IDO1) is the rate-limiting enzyme in the degradation of tryptophan to kynurenine. IDO1 is highly expressed in some tumor tissues. IDO1 can deplete tryptophan in tumor microenvironment, inhibit T cell function, and mediate the immune escape of tumor cells. Thus, IDO1 is considered a potential target of tumor immunotherapy. Currently, there are several IDO1 inhibitors in clinical research studies. The mechanism of IDO1-mediated tumor immune escape and the structure of IDO1 inhibitors are summarized in this review.
2.Research progress of KRAS inhibitors
Yan-zhao XU ; Hui WEN ; Hua-qing CUI
Acta Pharmaceutica Sinica 2021;56(6):1562-1570
The
3.Research progress on the development of human neutrophil elastase inhibitors
Zhong-wei WANG ; Hui WEN ; Yu-chen WANG ; Hua-qing CUI
Acta Pharmaceutica Sinica 2023;58(4):909-918
Human neutrophil elastase (hNE) is a serine proteolytic enzyme mainly distributed in neutrophils. When the balance between anti-hNE protein and hNE is broken, excessive release of hNE can cause the occurrence of various diseases. Therefore, inhibition of hNE is a promising therapeutic strategy. In this paper, the structure, action mechanism, physiological function of hNE and the development of hNE inhibitors were briefly summarized, in order to provide information for the related research.
4.Optimization of electroporation parameters in HL-60 cells for STIM1 siRNA interference during its differentiation.
Hai-Yang CHEN ; Wen-Ying ZOU ; Cui-Hua XIE ; Xiao-Jing MENG ; Chun-Qing CAI
Chinese Journal of Applied Physiology 2011;27(4):497-499
Cell Transformation, Neoplastic
;
drug effects
;
genetics
;
Dimethyl Sulfoxide
;
pharmacology
;
Electroporation
;
methods
;
HL-60 Cells
;
Humans
;
Membrane Proteins
;
genetics
;
Neoplasm Proteins
;
genetics
;
RNA Interference
;
RNA, Small Interfering
;
genetics
;
Stromal Interaction Molecule 1
;
Transfection
5.Anti-tumor effects of a novel cyclophosphamide derivate 9b in vivo and in vitro.
Pu-Mei CUI ; Li SHU ; Fei LIU ; Jun-Qing YANG ; Yang SONG ; Wen-Juan SUN
Acta Pharmaceutica Sinica 2014;49(1):44-49
This study is to investigate the anti-tumor activities of a novel cyclophosphamide derivate 4, 6-diphenyl cyclophosphamide (9b) in vivo and in vitro, and its possible mechanism of action. The inhibitory effects of 9b on human hepatoma cell line HepG2, human breast carcinoma cell line MCF-7 and human myeloid leukemia cell line K562 were measured by MTT assay in vitro. Cell cycle distribution and apoptotic rate were evaluated by flow cytometry. To evaluate the anti-tumor effect of 9b in vivo, mouse model bearing inoculated H22 tumor was established. The results indicated that 9b could inhibit the proliferation of HepG2, MCF-7 and K562 cells in a dose and time dependent manner. The ICo50 values of 9b were 32.34 micromol.L-1 to HepG2 cells, 87.07 micromol.L-1 to MCF-7 cells and 149.10 micromol.L-1 to K562 cells after incubation for 48 h. The results of flow cytometry indicated that after being treated for 48 h with different concentrations of 9b, the ratios of HepG2, MCF-7 cells at the Go/G1 phase and K562 cells at the G0/Gl phase and G2/M phase increased significantly compared with control group, and the apoptotic rate increased with the increase of the concentration of 9b. 9b could significantly reduce tumor weight of H22 solid tumor mouse model in vivo. To summarize, 9b showed significantly anti-tumor activity in vivo and in vitro, of which the mechanism might be associated with the change of cell cycle distribution and induction of tumor cell apoptosis.
Animals
;
Antineoplastic Agents, Alkylating
;
chemistry
;
pharmacology
;
Apoptosis
;
drug effects
;
Cell Cycle
;
drug effects
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Cyclophosphamide
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Dose-Response Relationship, Drug
;
Female
;
Humans
;
Inhibitory Concentration 50
;
Liver Neoplasms, Experimental
;
pathology
;
Male
;
Mice
;
Molecular Structure
;
Random Allocation
;
Tumor Burden
;
drug effects
6.Some Approaches for the Selective Isolation of Rare Actinomycetes
Wei XIAO ; Ming-Gang LI ; Xiao-Long CUI ; Yi-Qing LI ; Meng-Liang WEN ;
Microbiology 1992;0(01):-
The focus of microbiologists has moved to the rare actinomycetes.For selective isolation of rare actinomycetes that all play the important role in bioactive compounds,the approaches which involve the methods using gellan gum and flooding solution、 rehydration-centrifugation(RC)、 extremely high frequency radiation(EHF)、 bacteriophage and sucrose-gradient centrifugation were introduced in this paper.
7.Robotic surgical system combined with colonoscopy for colon tumor resection and D1 lymph node dissection.
Wen Ming CUI ; Yuan CHANG ; Wen Xiu WANG ; Quan Bo ZHOU ; Hai Feng SUN ; Qing Qing ZHANG ; Fu Qi WANG ; Yan Zhen ZHANG ; Wei Tang YUAN
Chinese Journal of Gastrointestinal Surgery 2022;25(8):731-733
9.The effect of partial body-weight supported treadmill training on hemiplegia patients caused by with cerebral infarction
Cui-Huan PAN ; Ai-Hua LUO ; En XU ; Wen-Wei WANG ; Qing-Chun GAO ; Tong YE ; Yi HUANG ;
Chinese Journal of Physical Medicine and Rehabilitation 2003;0(10):-
Objective To investigate the effect of partial body-weight supported treadmill training ( PBW- STT) on function of lower limbs, walk function, ADL performance and quality of life of hemiplegic patient induced by cerebral infarction. Methods A total of 132 cerebral infarction patients were divided into a control group (n = 69) and a training group( n = 63) randomly. Both groups accepted routine rehabilitation therapy, and the training group accepted PBWSTT at the same time in addition. Both groups were evaluated with regard to their walking ability, func- tion of lower limbs, ADL performance and their quality of life by using Functional Ambulation Category (FAC) , Fugl-Meyer assessment (FMA) , Barthel index (BI) and SF-36 before and after rehabilitation treatment. Results The function of lower limb, walking ability, ADL performance and the quality of life of both groups were improved significantly after treatment, and those in the training group were improved to a significantly greater extent than those in the control group ( P
10.Construction of tissue engineered porcine corneal stroma with skin fibroblasts
yan-qing, ZHANG ; wen-jie, ZHANG ; xiao-jie, HU ; guang-dong, ZHOU ; lei, CUI ; wei, LIU ; yi-lin, CAO
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(02):-
Objective To explore the feasibility of constructing tissue engineered porcine corneal stroma with skin fibroblasts in vivo.Methods Skin fibroblasts were isolated from embryonic porcine,cultured and expanded in vitro.Cells were labeled with green fluorescence protein(GFP) gene by retro-viral infection.Cells at passage 3 were seeded on polyglycolic acid(PGA) non-woven fibers to form a cell-scaffold complex.The complexes were then implanted into porcines' corneal stroma after culturing in vitro for 1 week.Engineered stroma was observed continuously and harvested after 8 weeks for gross and histological evaluation.PGA with corneal stromal cells was served as control. Results The engineered tissue in the stroma gradually became transparent over a period of 8 weeks,showing no difference with the control group.Histologically,the engineered stromal lamellar was relatively regular and similar to the control.The implanted cells were confirmed by GFP expression under fluorescent microscope.By transmission electron microscopy examination, no significant difference in the diameter of collagen fiber was observed between the engineered stroma and normal stroma. Conclusion Tissue engineered corneal stroma may be formed with skin fibroblasts in porcine corneal microenvironment.